Literature DB >> 28483309

Current Knowledge and Management of Hypersensitivity to Aspirin and NSAIDs.

Tanya M Laidlaw1, Katherine N Cahill2.   

Abstract

Aspirin and nonsteroidal anti-inflammatory drugs (NSAIDs) are some of the most common culprits of drug-induced hypersensitivity reactions, and can lead to a wide array of adverse effects. The accurate and timely diagnosis of aspirin and NSAID-induced hypersensitivity reactions is important for both patient safety and for the initiation of appropriate disease-specific management and treatment. Because there are no reliably validated in vitro tests available, aspirin and NSAID challenges are considered to be the criterion standard for the diagnosis of these hypersensitivity reactions, though in some patients the diagnosis can be made on the basis of a clear clinical history.
Copyright © 2017 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  AERD; Aspirin; Aspirin challenge; Aspirin desensitization; NSAID; Oral challenge; Samter triad

Mesh:

Substances:

Year:  2017        PMID: 28483309     DOI: 10.1016/j.jaip.2016.10.021

Source DB:  PubMed          Journal:  J Allergy Clin Immunol Pract


  17 in total

1.  Cross-reactivity and tolerability of celecoxib in adult patients with NSAID hypersensitivity.

Authors:  Lily Li; Tanya Laidlaw
Journal:  J Allergy Clin Immunol Pract       Date:  2019-05-14

2.  Aspirin allergy labeling after desensitization: education, communication, and patient safety.

Authors:  Jyotsna Mullur; Tanya M Laidlaw
Journal:  J Allergy Clin Immunol Pract       Date:  2020-06-22

3.  Objective validity of patient-reported symptoms in aspirin-exacerbated respiratory disease patients.

Authors:  Pooja P Patel; Jing Cui; Katherine N Cahill; Tanya M Laidlaw
Journal:  Clin Exp Allergy       Date:  2021-12-01       Impact factor: 5.018

4.  Safety, Outcomes, and Recommendations for Two-Step Outpatient Nonsteroidal Anti-Inflammatory Drug Challenges.

Authors:  Lily Li; Jillian Bensko; Kathleen Buchheit; Rebecca R Saff; Tanya M Laidlaw
Journal:  J Allergy Clin Immunol Pract       Date:  2021-11-17

Review 5.  The role of aspirin desensitization followed by oral aspirin therapy in managing patients with aspirin-exacerbated respiratory disease: A Work Group Report from the Rhinitis, Rhinosinusitis and Ocular Allergy Committee of the American Academy of Allergy, Asthma & Immunology.

Authors:  Whitney W Stevens; Elina Jerschow; Alan P Baptist; Larry Borish; John V Bosso; Kathleen M Buchheit; Katherine N Cahill; Paloma Campo; Seong H Cho; Anjeni Keswani; Joshua M Levy; Anil Nanda; Tanya M Laidlaw; Andrew A White
Journal:  J Allergy Clin Immunol       Date:  2020-12-09       Impact factor: 10.793

6.  Biomarkers for predicting response to aspirin therapy in aspirin-exacerbated respiratory disease.

Authors:  Katarzyna E Tyrak; Kinga Pajdzik; Bogdan Jakieła; Izabela Kupryś-Lipińska; Adam Ćmiel; Radosław Kacorzyk; Gabriela Trąd; Piotr Kuna; Marek Sanak; Lucyna Mastalerz
Journal:  Clin Exp Allergy       Date:  2021-05-11       Impact factor: 5.401

7.  Computed Tomography Findings in Patients with Samter's Triad: An Observational Study.

Authors:  Min Bum Kim; Gil Chai Lim; Jin A Park; Yoo Suk Kim; Jeong Hong Kim; Ju Wan Kang
Journal:  Open Med (Wars)       Date:  2019-02-26

8.  Phellinus linteus Grown on Germinated Brown Rice Inhibits IgE-Mediated Allergic Activity through the Suppression of FcεRI-Dependent Signaling Pathway In Vitro and In Vivo.

Authors:  Ha-Kyoung Kwon; Hye-Jin Park
Journal:  Evid Based Complement Alternat Med       Date:  2019-11-29       Impact factor: 2.629

9.  Impact of reported NSAID "allergies" on opioid use disorder in back pain.

Authors:  Lily Li; Yuchiao Chang; Shuang Song; Elena Losina; Karen H Costenbader; Tanya M Laidlaw
Journal:  J Allergy Clin Immunol       Date:  2020-09-09       Impact factor: 10.793

10.  Omalizumab for Aspirin Hypersensitivity and Leukotriene Overproduction in Aspirin-exacerbated Respiratory Disease. A Randomized Controlled Trial.

Authors:  Hiroaki Hayashi; Yuma Fukutomi; Chihiro Mitsui; Keiichi Kajiwara; Kentaro Watai; Yosuke Kamide; Yuto Nakamura; Yuto Hamada; Yasuhiro Tomita; Kiyoshi Sekiya; Takahiro Tsuburai; Kenji Izuhara; Keiko Wakahara; Naozumi Hashimoto; Yoshinori Hasegawa; Masami Taniguchi
Journal:  Am J Respir Crit Care Med       Date:  2020-06-15       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.